Nasdaq Jumps 270 Points; Silver Surges Over 8%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday’s Mid-Day Session
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Why Clene Shares Are Trading Sharply Lower Monday
Clene Inc. (NASDAQ: CLNN) shares are trading lower by 25.90% to $2.09 during Monday's pre-market session after the company announced topline results in the Healey ALS Platform trial of CNM-Au8.
Clene To Report HEALEY ALS Platform Trial Topline Results On Monday, October 3
Clene Inc. (NASDAQ:CLNN) along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of
Clene Nanomedicine Presents Updated Long-Term Survival Data From RESCUE-ALS Participants At 2022 AANEM Scientific Conference
Treatment with CNM-Au8 significantly improved long-term survival with approximately a 70% decreased risk of mortality vs. original placebo randomization
Comparable survival benefits were also
Recap Of Monday’s Biotech Catalysts – End Of the Day Summary
Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy…
Recap: Clene Q2 Earnings
Clene (NASDAQ:CLNN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements
Clene Inc (NASDAQ:CLNN) has announced topline results from the Phase 2 VISIONARY-MS trial of CNM-Au, an investigational gold nanocrystal suspension, in…